Oncobox
YC S17Walnut, US · 11 employees · 1 known investors
Oncobox provides genetic profiling of tumor samples to help oncologists select the most likely effective drug from existing targeted cancer therapies for individual patients with advanced cancer. The analysis examines tumor DNA, RNA, and molecular pathways to identify the most relevant drug targets and generates a clinical report recommending which treatments are most likely to work.
Digital HealthHealthtechMedical DevicesDrug discoveryOncologyUnited States of AmericaAmerica / Canada
Founders & leadership· Y Combinator alumni (S17)
Investors · 1
Competitors · 6
by search overlapOncoHealth10 shared keywordsOncoHealth provides oncology-specific utilization management and virtual supportive care services for health plans, employers, and their members with cancer. Its offerings include OneUM for prior authorization workflows and Iris, a virtual service giving members 24/7 access to oncology-trained nurses, mental health therapists, and dietitians.
OncoLens6 shared keywordsOncoLens is an AI-enabled digital health platform that extracts and analyzes structured and unstructured clinical, pathology, and lab data from EMRs to support oncology workflows such as tumor board operations, clinical trial matching, registry reporting, and real-world evidence generation. It serves cancer centers, oncology providers, and life science/pharma partners through its research network connecting them for trials and data projects.
Onco6 shared keywordsOnco provides cancer patients in India with access to expert oncologists, quality treatment centers, discounted cancer medicines, diagnostic tests, and support throughout their treatment journey. The platform connects patients with specialists, offers curated treatment packages, and provides survivor mentorship and remote answers to cancer-related queries.
OneOncology6 shared keywordsOneOncology invests in and partners with community oncology practices to deliver cancer care, helping them grow, diversify across specialties, and apply data and technology to improve performance. It operates a network of oncology and urology practices across the United States.
Onc4 shared keywordsOnc.AI develops the Onclara platform, which uses oncology real-world data to build predictive and prognostic AI models for cancer decision-making. Its products serve pharma companies with Phase IB/II clinical trial decisions and predict immunotherapy response and outcomes for metastatic lung cancer patients.
Oncosenx3 shared keywordsOncoSenX is a late-stage pre-clinical cancer therapeutics company developing treatments that target solid tumors based on transcriptional activity. Its system pairs a patented Proteo-Lipid Vehicle (PLV) delivery agent with plasmid DNA payloads that induce apoptosis in cancer cells while sparing adjacent cells.
Companies competing with Oncobox for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Oncobox do?
- Oncobox provides genetic profiling of tumor samples to help oncologists select the most likely effective drug from existing targeted cancer therapies for individual patients with advanced cancer. The analysis examines tumor DNA, RNA, and molecular pathways to identify the most relevant drug targets and generates a clinical report recommending which treatments are most likely to work.
- Who founded Oncobox?
- Oncobox was founded by Andrew Garazha, Anton Buzdin.
- Who are Oncobox's investors?
- Oncobox's investors include Y Combinator.
- Where is Oncobox headquartered?
- Oncobox is headquartered in Walnut, US.